CIK: 0001040508 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $8,361,894 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | DIVERSEY HLDGS LTD | 236,561,159 | $3,148,629 | 37.7% | $14.71 | — | ORD SHS | G28923103 |
| SGRY | SURGERY PARTNERS INC | 49,064,576 | $2,620,539 | 31.3% | $32.73 | +41.7% | COM | 86881A100 |
| — | CEREVEL THERAPEUTICS HLDNG I | 60,632,356 | $1,965,701 | 23.5% | $16.58 | — | COM | 15678U128 |
| AVAH | AVEANNA HEALTHCARE HLDGS INC | 81,600,880 | $603,847 | 7.2% | $11.86 | -38.8% | COM | 05356F105 |
| ADV | ADVANTAGE SOLUTIONS INC | 2,890,000 | $23,178 | 0.3% | $10.52 | -21.8% | COM CL A | 00791N102 |